Medicine & Life Sciences
Glucose
91%
Peptides
68%
Glucagon-Like Peptide 1
67%
Glucagon
52%
Type 2 Diabetes Mellitus
52%
gastric inhibitory polypeptide receptor
44%
Placebos
30%
Cross-Over Studies
27%
Intravenous Fat Emulsions
27%
Information Centers
26%
Systematic Reviews
25%
Sodium-Glucose Transporter 2 Inhibitors
24%
Symporters
23%
Insulin
21%
Bone Resorption
21%
Denmark
19%
Meta-Analysis
19%
Incretins
18%
Randomized Controlled Trials
18%
Polypharmacy
17%
Glucagon-Like Peptide-1 Receptor
16%
rGLP-1 protein
15%
Colesevelam Hydrochloride
15%
Hypoglycemia
15%
Chemical Compounds
Insulinotropic
100%
Polypeptide
49%
Glucagon-Like Peptide 1
40%
Glucagon
37%
Glucose
31%
Insulin Derivative
26%
Colesevelam
19%
Glucagon-Like Peptide-1 Receptor Agonist
16%
Intravenous Fat Emulsion
16%
Agent Interacting With Transmitter, Hormone or Drug Receptor
15%